Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer

Joseph Kim, Michelle E. Ko, Rebecca A. Nelson, Amanda Arrington, Carrie Luu, Ann E. Falor, Nicholas N. Nissen, Steven D Colquhoun, Arti Hurria, Gagandeep Singh

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Orthotopic liver transplantation (OLT) is the gold standard treatment for patients with early hepatocellular carcinoma (HCC). There are concerns about the efficacy of OLT for HCC in older patients, who we hypothesized might have poorer outcomes. Therefore, we sought to examine advanced age and its impact on OLT outcomes. Study Design The United Network for Organ Sharing database was queried for patients who underwent OLT for HCC from 1987 to 2009. Patients were divided into 3 age groups: 35 to 49 years old, 50 to 64 years old, and 65 years or older, and patient characteristics were compared. Univariate and multivariate analyses were performed to assess the impact of age on OLT outcomes. Results Of 10,238 patients with OLT for HCC, 16.5% (n = 1,688) of patients were 35 to 49 years old, 67.8% (n = 6,937) were 35 to 49 years old, and 15.8% (n = 1,613) were 65 years and older. By Kaplan-Meier method, the 50- to 64-year-old age group had the highest overall survival, despite having one of the highest rates of hepatitis C positivity (70%), but this group also had the lowest rate of diabetes mellitus (8.7%). The lowest overall survival was observed in the 65-year or older age group (p < 0.001). Finally, there was no difference in disease-specific survival among the age groups (p = 0.858), and patients aged 65 years and older had the highest rate of death from nonhepatic causes (17.5%). Conclusions Although OS was prolonged in younger patients who underwent OLT for HCC, there was no observed difference in disease-specific survival among the age groups. Our results suggest that carefully selected patients 65 years of age and older can derive equal benefit from OLT for HCC when compared with their younger counterparts.

Original languageEnglish (US)
Pages (from-to)431-438
Number of pages8
JournalJournal of the American College of Surgeons
Volume218
Issue number3
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Liver Neoplasms
Liver Transplantation
Survival
Hepatocellular Carcinoma
Age Groups
Hepatitis C
Cause of Death
Diabetes Mellitus
Multivariate Analysis
Databases
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer. / Kim, Joseph; Ko, Michelle E.; Nelson, Rebecca A.; Arrington, Amanda; Luu, Carrie; Falor, Ann E.; Nissen, Nicholas N.; Colquhoun, Steven D; Hurria, Arti; Singh, Gagandeep.

In: Journal of the American College of Surgeons, Vol. 218, No. 3, 01.03.2014, p. 431-438.

Research output: Contribution to journalArticle

Kim, Joseph ; Ko, Michelle E. ; Nelson, Rebecca A. ; Arrington, Amanda ; Luu, Carrie ; Falor, Ann E. ; Nissen, Nicholas N. ; Colquhoun, Steven D ; Hurria, Arti ; Singh, Gagandeep. / Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer. In: Journal of the American College of Surgeons. 2014 ; Vol. 218, No. 3. pp. 431-438.
@article{b37aa0425cfb437cbef27dcd2eaba55e,
title = "Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer",
abstract = "Background Orthotopic liver transplantation (OLT) is the gold standard treatment for patients with early hepatocellular carcinoma (HCC). There are concerns about the efficacy of OLT for HCC in older patients, who we hypothesized might have poorer outcomes. Therefore, we sought to examine advanced age and its impact on OLT outcomes. Study Design The United Network for Organ Sharing database was queried for patients who underwent OLT for HCC from 1987 to 2009. Patients were divided into 3 age groups: 35 to 49 years old, 50 to 64 years old, and 65 years or older, and patient characteristics were compared. Univariate and multivariate analyses were performed to assess the impact of age on OLT outcomes. Results Of 10,238 patients with OLT for HCC, 16.5{\%} (n = 1,688) of patients were 35 to 49 years old, 67.8{\%} (n = 6,937) were 35 to 49 years old, and 15.8{\%} (n = 1,613) were 65 years and older. By Kaplan-Meier method, the 50- to 64-year-old age group had the highest overall survival, despite having one of the highest rates of hepatitis C positivity (70{\%}), but this group also had the lowest rate of diabetes mellitus (8.7{\%}). The lowest overall survival was observed in the 65-year or older age group (p < 0.001). Finally, there was no difference in disease-specific survival among the age groups (p = 0.858), and patients aged 65 years and older had the highest rate of death from nonhepatic causes (17.5{\%}). Conclusions Although OS was prolonged in younger patients who underwent OLT for HCC, there was no observed difference in disease-specific survival among the age groups. Our results suggest that carefully selected patients 65 years of age and older can derive equal benefit from OLT for HCC when compared with their younger counterparts.",
author = "Joseph Kim and Ko, {Michelle E.} and Nelson, {Rebecca A.} and Amanda Arrington and Carrie Luu and Falor, {Ann E.} and Nissen, {Nicholas N.} and Colquhoun, {Steven D} and Arti Hurria and Gagandeep Singh",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.jamcollsurg.2013.12.001",
language = "English (US)",
volume = "218",
pages = "431--438",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer

AU - Kim, Joseph

AU - Ko, Michelle E.

AU - Nelson, Rebecca A.

AU - Arrington, Amanda

AU - Luu, Carrie

AU - Falor, Ann E.

AU - Nissen, Nicholas N.

AU - Colquhoun, Steven D

AU - Hurria, Arti

AU - Singh, Gagandeep

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Background Orthotopic liver transplantation (OLT) is the gold standard treatment for patients with early hepatocellular carcinoma (HCC). There are concerns about the efficacy of OLT for HCC in older patients, who we hypothesized might have poorer outcomes. Therefore, we sought to examine advanced age and its impact on OLT outcomes. Study Design The United Network for Organ Sharing database was queried for patients who underwent OLT for HCC from 1987 to 2009. Patients were divided into 3 age groups: 35 to 49 years old, 50 to 64 years old, and 65 years or older, and patient characteristics were compared. Univariate and multivariate analyses were performed to assess the impact of age on OLT outcomes. Results Of 10,238 patients with OLT for HCC, 16.5% (n = 1,688) of patients were 35 to 49 years old, 67.8% (n = 6,937) were 35 to 49 years old, and 15.8% (n = 1,613) were 65 years and older. By Kaplan-Meier method, the 50- to 64-year-old age group had the highest overall survival, despite having one of the highest rates of hepatitis C positivity (70%), but this group also had the lowest rate of diabetes mellitus (8.7%). The lowest overall survival was observed in the 65-year or older age group (p < 0.001). Finally, there was no difference in disease-specific survival among the age groups (p = 0.858), and patients aged 65 years and older had the highest rate of death from nonhepatic causes (17.5%). Conclusions Although OS was prolonged in younger patients who underwent OLT for HCC, there was no observed difference in disease-specific survival among the age groups. Our results suggest that carefully selected patients 65 years of age and older can derive equal benefit from OLT for HCC when compared with their younger counterparts.

AB - Background Orthotopic liver transplantation (OLT) is the gold standard treatment for patients with early hepatocellular carcinoma (HCC). There are concerns about the efficacy of OLT for HCC in older patients, who we hypothesized might have poorer outcomes. Therefore, we sought to examine advanced age and its impact on OLT outcomes. Study Design The United Network for Organ Sharing database was queried for patients who underwent OLT for HCC from 1987 to 2009. Patients were divided into 3 age groups: 35 to 49 years old, 50 to 64 years old, and 65 years or older, and patient characteristics were compared. Univariate and multivariate analyses were performed to assess the impact of age on OLT outcomes. Results Of 10,238 patients with OLT for HCC, 16.5% (n = 1,688) of patients were 35 to 49 years old, 67.8% (n = 6,937) were 35 to 49 years old, and 15.8% (n = 1,613) were 65 years and older. By Kaplan-Meier method, the 50- to 64-year-old age group had the highest overall survival, despite having one of the highest rates of hepatitis C positivity (70%), but this group also had the lowest rate of diabetes mellitus (8.7%). The lowest overall survival was observed in the 65-year or older age group (p < 0.001). Finally, there was no difference in disease-specific survival among the age groups (p = 0.858), and patients aged 65 years and older had the highest rate of death from nonhepatic causes (17.5%). Conclusions Although OS was prolonged in younger patients who underwent OLT for HCC, there was no observed difference in disease-specific survival among the age groups. Our results suggest that carefully selected patients 65 years of age and older can derive equal benefit from OLT for HCC when compared with their younger counterparts.

UR - http://www.scopus.com/inward/record.url?scp=84894297727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894297727&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2013.12.001

DO - 10.1016/j.jamcollsurg.2013.12.001

M3 - Article

C2 - 24559955

AN - SCOPUS:84894297727

VL - 218

SP - 431

EP - 438

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 3

ER -